Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Vermillion, Inc.

NASDAQ: VRMLHealthcare / Diagnostic Substances / USA
0.7900+0.0700+9.72%Vol 146 0721Y Perf -51.86%
Jan 18th, 2019 16:00
BID0.7000 ASK0.8500
Open0.6900 Previous Close0.7300
Pre-Market- After-Trading0.80
 - -%  0.01 1.27%
Target Price
2.25 
Analyst Rating
Hold 3.00
Potencial %
184.81 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/20/43 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/88/99 
Growth Ranking
★★+     48.57
Insiders Shares Cnt. % 3/6/12M
100/87/99 
Income Ranking
 —    -
Market Cap (mil)60 
Earnings Rating
Neutral
Price Range Ratio 52wk %
35.37 
Earnings Date
12th Mar 2019

Today's Price Range

0.69000.8000

 

52wk Range

0.27001.74

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
97.50%
3 Months
68.09%
6 Months
9.72%
1 Year
-51.86%
3 Years
-46.26%
5 Years
-71.99%

Quotes

Name / TickerPriceChg.Chg.%
VRML0.79000.07009.72
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.10
Current Ratio
5.30
Long Term Debt to Total Capital
0.12
Total Debt to Equity
0.16
Interest Coverage
-327.70
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-5.90
EBIT Margin
-391.60
EBITDA Margin
-367.30
Pre-tax Profit Margin
-575.80
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
4.44
PS Ratios
20.22
Price to Cash Flow
-
Price to Free Cash Flow
-6.00
Cash Flow Per Share
-0.14
Price to Tangible Book
4.44
Book Value per Share
0.13
Enterprise Value (in ths.)
32 849
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-103.06
ROE last 12 Months
-147.22
Return on Assets (5Y Avg)
-127.07
ROA last 12 Months
-99.40
Return on Capital (5Y Avg)
-147.58
ROC last 12 Months
-121.53
Return on invested Capital Q
-21.27
Return on invested Capital Y
-213.35
Assets Turnover
0.10
Receivables Turnover
2.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 131
Revenue per Share
0.03
Revenue Growth 3 Years
3.43
Revenue Growth 5 Years
0.24
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q04 2016--0.05-
Q02 2016--0.07-
Q01 2016--0.09-
Q04 2015--0.10-
Q03 2015-0.10-0.100.00
Q02 2015-0.08-0.11-37.50
Q01 2015-0.10-0.100.00
Q04 2014-0.08-0.11-37.50
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date12th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume146 072
Shares Outstanding (in ths.)75 383
Trades Count247
Dollar Volume105 869
Avg. Volume227 242
Avg. Weekly Volume418 550
Avg. Monthly Volume236 143
Avg. Quarterly Volume154 214

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

71%29%

Bearish Bullish

46%54%

Bearish Bullish

42%58%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News